Interstitial fluid sampling above microneedle array

Patent metadata

Field	Value
Publication number	US-10105080-B1
Application number	US-201414583978-A
Country	US
Kind code	B1
Filing date	Dec 29, 2014
Priority date	Oct 24, 2014
Publication date	Oct 23, 2018
Grant date	Oct 23, 2018

Abstract

Devices are provided that include a plurality of microneedles that penetrate skin and that receive interstitial fluid from the skin tissue. The microneedles are further configured to direct the received interstitial fluid to nanosensors configured to change an optical property based on interaction with an analyte in the received interstitial fluid, allowing optical detection of the analyte. Direction of the received interstitial fluid to the nanosensors can be facilitated by a pump configured to control the flow rate of the interstitial fluid through the microneedles. Such devices could be configured to detect the analyte independently or in combination with a reader device configured to be periodically mounted to the devices and to detect the analyte. Further, such devices can include delivery systems configured to transdermally deliver a drug or other substance into or through the skin in response to a detected concentration, presence, or other property of the analyte.

First claim

What is claimed is:

1. A system comprising:
a plurality of nanosensors, wherein each nanosensor comprises a nanoparticle and an analyte-selective agent that selectively interacts with an analyte present in interstitial fluid, wherein the analyte-selective agent is disposed on a surface of the nanoparticle or within an interior of the nanoparticle, and wherein each nanosensor has an optical property that changes in response to interaction with the analyte;
a detector;
a plurality of microneedles, wherein each microneedle comprises (i) a first end shaped to penetrate skin, (ii) a second end opposite the first end, and (iii) a channel that extends from a first opening proximate the first end to a second opening proximate the second end such that interstitial fluid is received into the channel via the first opening when the microneedle penetrates the skin, and wherein the nanosensors are disposed relative to the microneedles such that the microneedles direct the received interstitial fluid to the nanosensors via the channels; and
a controller operably coupled to the detector, wherein the controller comprises a processor and data storage that stores program instructions, wherein the program instructions are executable by the processor to perform controller operations comprising:
operating the detector to detect the optical property of the nanosensors; and
detecting the analyte in the received interstitial fluid based on the detected optical property of the nanosensors,

wherein the analyte is an ion; and
wherein each nanosensor comprises:
an ionophore, wherein the ionophore selectively interacts with the ion;
a linking agent, wherein the linking agent changes a local pH in response to the ionophore selectively interacting with the ion; and
a fluorophore, wherein the fluorophore is a pH-sensitive fluorophore having a fluorescent property that is dependent upon the local pH.

2. The system of claim 1 , further comprising:
a plurality of further nanosensors, wherein each further nanosensor comprises a nanoparticle that selectively interacts with a further analyte present in interstitial fluid, and wherein each further nanosensor has an optical property that changes in response to interaction with the further analyte;
a further detector, wherein the controller is operably coupled to the further detector;
a plurality of further microneedles, wherein each further microneedle comprises (i) a first end shaped to penetrate skin, (ii) a second end opposite the first end, and (iii) a further channel that extends from a first opening proximate the first end to a second opening proximate the second end such that interstitial fluid is received into the channel via the first opening when the further microneedle penetrates the skin, wherein the further nanosensors are disposed relative to the further microneedles such that the further microneedles direct the interstitial fluid to the further nanosensors via the channels, and wherein the controller operations further comprise:
operating the further detector to detect the optical property of the further nanosensors; and
detecting the further analyte in the received interstitial fluid based on the detected optical property of the further nanosensors.

3. The system of claim 1 , wherein operating the detector to detect the optical property of the nanosensors comprises:
illuminating the nanosensors, using a light source of the detector, with light at an excitation wavelength of the fluorophore; and
receiving light emitted from the nanosensors in response to the illumination at an emission wavelength of the fluorophore, using a light sensor of the detector.

4. The system of claim 1 , wherein the detector and the controller are disposed in a reader device, wherein the microneedles and nanosensors are disposed in a skin-mountable patch, and wherein the reader device is reversibly mountable to the skin-mountable patch.

5. The system of claim 4 , wherein the reader device comprises one or more actuators to mount the skin-mountable patch to skin such that the microneedles penetrate the skin.

6. The system of claim 1 , wherein the system comprises a wearable device mountable to skin such that the microneedles penetrate the skin, wherein the wearable device comprises the detector, the microneedles, the nanosensors, and the controller.

7. The system of claim 1 , wherein each microneedle further comprises a hydrophilic coating disposed on an inside surface of the channel.

8. The system of claim 1 , wherein the nanosensors are disposed within the channels of the microneedles.

9. The system of claim 1 , wherein the nanosensors are disposed outside of the channels of the microneedles and proximate to the second ends of the microneedles, such that the microneedles direct the received interstitial fluid to the nanosensors via the channels and the second openings.

10. The system of claim 1 , further comprising a pump coupled to the microneedles, wherein the pump controls a flow rate of the received interstitial fluid through the channels of the microneedles.

11. The system of claim 1 , further comprising:
a drug reservoir that stores an amount of a drug, wherein the controller operations further comprise:
controlling transdermal delivery of the drug based on the detected analyte.

12. A method comprising:
penetrating skin with a plurality of microneedles, wherein each microneedle comprises (i) a first end configured to penetrate the skin, (ii) a second end opposite the first end, and (iii) a channel that extends from a first opening proximate the first end to a second opening proximate the second end;
receiving interstitial fluid into the channels of the microneedles via the first openings of the microneedles;
directing the received interstitial fluid to a plurality of nanosensors via the channels of the microneedles, wherein each nanosensor comprises a nanoparticle and an analyte-selective agent that selectively interacts with an analyte present in the interstitial fluid, wherein the analyte-selective agent is disposed on a surface of the nanoparticle or within an interior of the nanoparticle, and wherein each nanosensor has an optical property that changes in response to interaction with the analyte;
operating a detector to detect the optical property of the nanosensors; and
detecting the analyte in the received interstitial fluid based on the detected optical property of the nanosensors,
wherein the analyte is an ion; and
wherein each nanosensor comprises:
an ionophore, wherein the ionophore selectively interacts with the ion;
a linking agent, wherein the linking agent changes a local pH in response to the ionophore selectively interacting with the ion; and
a fluorophore, wherein the fluorophore is a pH-sensitive fluorophore having a fluorescent property that is dependent upon the local pH.

13. The method of claim 12 , wherein operating the detector to detect the optical property of the nanosensors comprises:
illuminating the nanosensors, using a light source of the detector, with light at an excitation wavelength of the fluorophore; and
receiving light emitted from the nanosensors in response to the illumination at an emission wavelength of the fluorophore, using a light sensor of the detector.

14. The method of claim 12 , further comprising:
controlling a flow rate of the received interstitial fluid through the channels of the microneedles using a pump.

15. The method of claim 12 , wherein operating the detector to detect the optical property of the nanosensors and detecting the analyte in the received interstitial fluid based on the detected optical property of

Assignees

• Verily Life Sciences Llc

Inventors

• Kam Kimberly
• Schwartz Jerrod Joseph
• Tong Gary

Classifications

• A61B5/4839

  combined with drug delivery · CPC title

• A61B5/6833

  Adhesive patches · CPC title

• A61B5/14514 Primary

  using means for aiding extraction of interstitial fluid, e.g. microneedles or suction · CPC title

• A61M2005/1726

  the body parameters being measured at, or proximate to, the infusion site · CPC title

• A61B10/0045

  Devices for taking samples of body liquids · CPC title